logo-loader

ChemioCare CEO says financing efforts reach new milestone

Published: 08:35 06 May 2019 EDT

ChemioCare USA Inc CEO Pedro Lichtinger tells Proactive Investors the privately-held biotech company has reached half of the $5 million target for its ongoing Series B financing.

Lichtinger also says the company is kicking off the development of a new transdermal formulation, and has added a retired Pfizer (NYSE:PFE) executive to its board.

Coniagas Battery Metals secures new key ground with focus on...

Coniagas Battery Metals (TSX-V:COS) CEO Frank Basa joined Steve Darling from Proactive to announce the company's strategic acquisition of key ground near SOQUEM’s Cardinal Property, located 80 km southeast of Chibougamau, Quebec. This acquisition underscores Coniagas’ commitment to capitalizing...

13 minutes ago